Skip to main content
Have a personal or library account? Click to login
Studies in 3,4-diaryl-1,2,5-oxadiazoles and their N-oxides: Search for better COX-2 inhibitors Cover

Studies in 3,4-diaryl-1,2,5-oxadiazoles and their N-oxides: Search for better COX-2 inhibitors

Acta Pharmaceutica
Volume 57 (2007): Issue 1 (March 2007)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Mar 2007
References

References

  1. T. D. Warner and J. A. Mitchell, Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic,18 (2004) 790-804.
    Search in Google Scholar
  2. E. M. Antman, D. DeMets and J. Loscalzo, Cyclooxygenase inhibition and cardiovascular risk,112 (2005) 759-770.
    Open DOISearch in Google Scholar
  3. J. J. Li, G. D. Anderson, E. G. Burton, J. N. Cogburn, J. T. Collins, D. J. Garland, S. A. Gregory, H. C. Huang, P. C. Isakson, C. M. Koboldt, E. W. Logusch, M. B. Norton, W. E. Perkins, E. J. Reinhard, K. Seibert, A. W. Veenhuizen, Y. Zhang and D. B. Reitz, 1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents,38 (1995) 4570-4578.
    Open DOISearch in Google Scholar
  4. T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, M. J. Graneto, F. J. Lee, J. W. Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier, S. S. Yu, G. A. Anderson, F. G. Burton, J. N. Cogburn, S. A. Gragory, C. M. Koboldt, W. E. Perkins, K. Seibert, A. W. Veenhuizen, Y. Y. Zhang and P. C. Isakson, Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl) -1-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib),40 (1997) 1347-1365.
    Search in Google Scholar
  5. G. Dannhardt and W. Kiefer, Cyclooxygenase inhibitors - current status and future prospects,36 (2001) 109-126.
    Open DOISearch in Google Scholar
  6. P. Prasit, Z. Wang, C. Brideau, C. C. Chan, S. Charleson, W. Cromlish, D. Either, J. F. Evans, A. W. Ford-Hutchinson, J. Y. Gauthier, R. Gordon, J. Guay, M. Gresser, S. Kargman, B. Kennedy, Y. Leblanc, S. Leger, J. Mancini, G. P. O'Neil, M. Ouellet, M. D. Percieval, H. Perrier, D. Riendeau, I. Rodger, P. Tagari, M. Therien, P. Vickers, E. Wong, L. J. Xu, R. N. Young, R. Zamboni, S. Boyce, N. Rupniak, M. Forrest, D. Visco and D. Patrick, The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5)-furanone], an orally active cyclooxy-genase-2 inhibitor,9 (1999) 1773-1778.
    Open DOISearch in Google Scholar
  7. J. J. Tally, D. L. Brown, J. S. Carter, M. J. Graneto, C. M. Koboldt, J. L. Masferrer, W. E. Perkins, R. S. Rogers, A. F. Shaffer, Y. Y. Zhang, B. S. Zweifel and K. Seibert, 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2,43 (2000) 775-777.
    Search in Google Scholar
  8. J. J. Tally, S. R. Bertenshaw, D. L. Brown, J. S. Carter, M. J. Graneto, M. S. Kellogg, C. M. Koboldt, J. Yuan, Y. Y. Zhang and K. Seibert,[[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration,43 (2000) 1661-1663.
    Search in Google Scholar
  9. D. Riendeau, M. D. Percieval, C. Brideau, S. Charleson, D. Dube, D. Ethier, J. P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. J. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C. C. Chan, Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2,296 (2001) 558-570.
    Search in Google Scholar
  10. M. R. Yadav, R. Giridhar and H. B. Prajapati,, Indian Patent Appl. No. 109/MUM/2004, Feb. 2004.
    Search in Google Scholar
  11. H. Cerecetto and W. Porcal, Pharmacological properties of furoxans and benzofuroxans: Recent developments,5 (2005) 57-71.
    Open DOISearch in Google Scholar
  12. V. G. Granik and N. B. Grigor, Nitric oxide synthase inhibitors: Biology and Chemistry,51 (2002) 1973-1995.
    Open DOISearch in Google Scholar
  13. C. Velazquez, P. N. P. Rao, R. McDonald and E. E. Knaus, Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents,13 (2005) 2749-2757.
    Open DOISearch in Google Scholar
  14. J. S. Buck and W. S. Ide, Mixed benzoins. I,52 (1930) 220-224.
    Open DOISearch in Google Scholar
  15. J. S. Buck and W. S. Ide, Mixed benzoins. II,52 (1930) 4107-4109.
    Open DOISearch in Google Scholar
  16. S. T. Shirude, P. Patel, R. Giridhar and M. R. Yadav, An efficient and time saving microwave assisted selenium dioxide oxidation of 1,2-diarylethanones,45B (2006) 1080-1085.
    Open DOISearch in Google Scholar
  17. H. Sano, T. Noguchi, A. Tanatani, Y. Hashimoto and H. Miyachi, Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide,13 (2005) 3079-3091.
    Open DOISearch in Google Scholar
  18. C. A. Winter, E. A. Risley and G. W. Nuss, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs,111 (1962) 544-547.
    Open DOISearch in Google Scholar
  19. Molecular modeling system, version 6.9, Tripos, Inc., St. Louis, USA, (2003).
    Search in Google Scholar
  20. R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic, D. T. Mainz, M. P. Repasky, E. H. Knoll, M. Shelly, J. K. Perry, D. E. Shaw, P. Francis and P. S. Shenkin, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy,47 (2004) 1739-1749.
    Search in Google Scholar
  21. M. Clark, R. D. Crammer and N. van Opdenbosh, Validation of the General-Purpose Tripos 5.2 force field,10 (1989) 982-1012.
    Open DOISearch in Google Scholar
  22. J. H. Boyer, R. F. Reinisch, M. J. Danzig, G. A. Stoner and F. Sahhar, The transformation of ψ-o-dinitroso aromatic compounds into o-nitroaryl amines,77 (1955) 5688-5690.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10007-007-0002-z | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 13 - 30
Published on: Mar 8, 2007
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
1,2,5-oxadiazole,
1,2,5-oxadiazole N-oxide,
COX-2 inhibitor
Related subjects:
Pharmacy,
Pharmacy, other

© 2007 Mange Yadav, Shrikant Shirude, Devendra Puntambekar, Pinkal Patel, Hetal Prajapati, Arvind Parmar, R. Balaraman, Rajani Giridhar, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 57 (2007): Issue 1 (March 2007)
Previous article
Next article